Maze Therapeutics, Inc. (MAZE) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Maze Therapeutics, Inc. (MAZE) Company Statistics | The Fly

Maze Therapeutics, Inc.

· MAZE

Dashboard

Financials

Ratios

Valuation

Statistics

1.501 B

+0.59%

General

Market Cap: $1.5B
Enterprise Value: $1.36B
Shares Outstanding: 55,350,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 95.28%
Operating Margin: -728.06%
Net Profit Margin: -667.95%
FCF Margin: -534.20%
ROA: -25.13%
ROE: -34.94%
ROIC: -28.35%
Current Ratio: 18.31
Debt-to-Equity: 0.13
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.21
P/S: 75.21
P/FCF: —
P/B: 3.32
EV/EBITDA: -10.45

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —

Income Statement (TTM)

Revenue: $20M
Gross Margin: 95.28%
Operating Expenses: $164.67M
Operating Income: -$145.61M
Net Profit: -$133.59M

Balance Sheet

EPS 10Y (CAGR)

—

Cash and Equivalents: $202.64M
Working Capital: $397.46M
Total Assets: $531.63M
Net Debt: -$142.22M
Total Liabilities: $78.5M
Total Equity: $453.12M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$106.54M
Cash Flow from Investing: -$292.5M
Cash Flow from Financing: $337.14M
Free Cash Flow: -$106.84M
Capital Expenditures: $302K